Home  »  Industry   »  Here is why Kiniksa Pharmaceuticals Ltd. (KNSA) st...

Here is why Kiniksa Pharmaceuticals Ltd. (KNSA) stock volatility recorded over the last month was 6.69%

At the end of the latest market close, Kiniksa Pharmaceuticals Ltd. (KNSA) was valued at $15.86. In that particular session, Stock kicked-off at the price of $16.02 while reaching the peak value of $16.78 and lowest value recorded on the day was $15.54. The stock current value is $15.60.

Kiniksa Pharmaceuticals Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $16.78 on 11/23/22, with the lowest value was $7.36 for the same time period, recorded on 06/01/22.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Kiniksa Pharmaceuticals Ltd. (KNSA) full year performance was 32.20%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kiniksa Pharmaceuticals Ltd. shares are logging -6.40% during the 52-week period from high price, and 111.96% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.36 and $16.67.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 332932 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Kiniksa Pharmaceuticals Ltd. (KNSA) recorded performance in the market was 32.54%, having the revenues showcasing 21.97% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.06B, as it employees total of 215 workers.

The Analysts eye on Kiniksa Pharmaceuticals Ltd. (KNSA)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.34, with a change in the price was noted +4.53. In a similar fashion, Kiniksa Pharmaceuticals Ltd. posted a movement of +40.92% for the period of last 100 days, recording 353,918 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for KNSA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Kiniksa Pharmaceuticals Ltd. (KNSA)

Raw Stochastic average of Kiniksa Pharmaceuticals Ltd. in the period of last 50 days is set at 82.24%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.85%. In the last 20 days, the company’s Stochastic %K was 83.60% and its Stochastic %D was recorded 85.75%.

Considering, the past performance of Kiniksa Pharmaceuticals Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 32.54%. Additionally, trading for the stock in the period of the last six months notably improved by 91.65%, alongside a boost of 32.20% for the period of the last 12 months. The shares increased approximately by -1.58% in the 7-day charts and went down by 29.03% in the period of the last 30 days. Common stock shares were driven by 21.97% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts